BIOPHARMA HOLDING ApS: Financial statements 2018
CVR: 35206086
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
BIOPHARMA HOLDING ApS (CVR 35206086) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 404,990 and a net result of DKK 1,373,309 compared with DKK -8,154,301 the year before. That is an increase of 35.9% compared with the year before. Equity in the 2018 report amounted to DKK 120,400,966. The solvency ratio was 99.2%.
- Gross Profit
- DKK 404,990
- Profit/Loss
- DKK 1,373,309
- Equity
- DKK 120,400,966
- Total Assets
- DKK 121,400,355
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 405 t. | 1.4 mio. | 120.4 mio. | 0 |
| 2017 | - | 298 t. | -8.2 mio. | 119 mio. | 1 |
| 2016 | - | 379 t. | -6.9 mio. | 127.2 mio. | 2 |
| 2015 | - | 149 t. | -200.3 mio. | 134 mio. | - |
| 2014 | - | 183 t. | 10.6 mio. | 334.4 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
BIOPHARMA HOLDING ApS has published its annual report for 2017. Gross profit came to DKK 298,043, and the net result was DKK -8,154,301.
About BIOPHARMA HOLDING ApS
BIOPHARMA HOLDING ApS was a Danish company of the type Anpartsselskab based in Hørsholm, founded in 2013. The company has been dissolved on 17 July 2026. The company was registered under the industry Finansielle holdingselskaber. The company has 1 employee (2017). In 2024, the company reported a gross profit of DKK 921,360 and a net result of DKK -3,732,682 compared with DKK -20,576,349 the year before. Equity in the 2024 report amounted to DKK 2,921,095.